Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis
Gespeichert in:
| Veröffentlicht in: | British journal of haematology 2023-05, Vol.201 (3), p.568-572 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 572 |
|---|---|
| container_issue | 3 |
| container_start_page | 568 |
| container_title | British journal of haematology |
| container_volume | 201 |
| creator | Wang, Huafeng Yao, Yiyi Mao, Liping Lou, Yinjun Ren, Yanling Ye, Xingnong Yang, Min Ma, Liya Zhang, Yi Zhou, Yile Wu, Jiaying Huang, Xin Wang, Yungui Xu, Huan Tong, Hongyan Zhu, Hong‐Hu Jin, Jie |
| description | |
| doi_str_mv | 10.1111/bjh.18709 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2783497237</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2783497237</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3889-aa24c9db643c9c08a5c064fcffcbb8488ded08704f07ae82c5270249dd5d22e93</originalsourceid><addsrcrecordid>eNp1kbtuFDEUhkcIRJZAwQsgSzQgNIk9Vw8dREBAkWiAdnTGPsN68diDLwnTbUtHCY_FK-yT4GUDBRKWLDff_-kc_1l2n9ETls7psFmfMN7S7ka2YmVT5wWr2M1sRSltc0YrfpTd8X5DKStpzW5nR2XDmzLxq-znBzQYrNDwhcw6erLbfi92269P0q132x9kslKNCiVRJqDx6hKJWONkwxodzAu5UmFNJERjXRyUUIaAkUQsARwMymDKkVEFglqi0wuZISg0wR-C0QSHEJJeIjH20hIQMSCZFtRWSaIxfgKcFDwlQLwyHzXutt8E7mPEYXDWzyjCfiowoBev_N3s1gja473r9zh7__LFu7Pz_OLtq9dnzy5yUXLe5QBFJTo5NFUpOkE51II21SjGUQwDrziXKGn602qkLSAvRF20tKg6KWtZFNiVx9mjg3d29nNEH_pJeYFag0EbfV-0vKy6tijbhD78B93Y6NK8ieJJ2pYtaxL1-ECJtJV3OPazUxO4pWe03_fcp5773z0n9sG1MQ4Tyr_kn2ITcHoArpTG5f-m_vmb84PyF_97u8Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2802473716</pqid></control><display><type>article</type><title>Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Free Content</source><creator>Wang, Huafeng ; Yao, Yiyi ; Mao, Liping ; Lou, Yinjun ; Ren, Yanling ; Ye, Xingnong ; Yang, Min ; Ma, Liya ; Zhang, Yi ; Zhou, Yile ; Wu, Jiaying ; Huang, Xin ; Wang, Yungui ; Xu, Huan ; Tong, Hongyan ; Zhu, Hong‐Hu ; Jin, Jie</creator><creatorcontrib>Wang, Huafeng ; Yao, Yiyi ; Mao, Liping ; Lou, Yinjun ; Ren, Yanling ; Ye, Xingnong ; Yang, Min ; Ma, Liya ; Zhang, Yi ; Zhou, Yile ; Wu, Jiaying ; Huang, Xin ; Wang, Yungui ; Xu, Huan ; Tong, Hongyan ; Zhu, Hong‐Hu ; Jin, Jie</creatorcontrib><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.18709</identifier><identifier>PMID: 36863709</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>acute myeloid leukaemia ; Acute myeloid leukemia ; Aged ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Bridged Bicyclo Compounds, Heterocyclic - therapeutic use ; Chemotherapy ; Cytarabine ; Cytarabine - therapeutic use ; Daunorubicin ; Daunorubicin - therapeutic use ; DAV ; efficacy ; Hematology ; Humans ; Leukemia, Myeloid, Acute - etiology ; Remission Induction ; Retrospective Studies ; safety ; venetoclax</subject><ispartof>British journal of haematology, 2023-05, Vol.201 (3), p.568-572</ispartof><rights>2023 British Society for Haematology and John Wiley & Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3889-aa24c9db643c9c08a5c064fcffcbb8488ded08704f07ae82c5270249dd5d22e93</citedby><cites>FETCH-LOGICAL-c3889-aa24c9db643c9c08a5c064fcffcbb8488ded08704f07ae82c5270249dd5d22e93</cites><orcidid>0000-0003-3625-2288 ; 0000-0003-2343-0436 ; 0000-0001-8428-1791 ; 0000-0002-8360-6395 ; 0000-0002-4420-0480 ; 0000-0002-8166-9915</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjh.18709$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjh.18709$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27903,27904,45553,45554,46387,46811</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36863709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Huafeng</creatorcontrib><creatorcontrib>Yao, Yiyi</creatorcontrib><creatorcontrib>Mao, Liping</creatorcontrib><creatorcontrib>Lou, Yinjun</creatorcontrib><creatorcontrib>Ren, Yanling</creatorcontrib><creatorcontrib>Ye, Xingnong</creatorcontrib><creatorcontrib>Yang, Min</creatorcontrib><creatorcontrib>Ma, Liya</creatorcontrib><creatorcontrib>Zhang, Yi</creatorcontrib><creatorcontrib>Zhou, Yile</creatorcontrib><creatorcontrib>Wu, Jiaying</creatorcontrib><creatorcontrib>Huang, Xin</creatorcontrib><creatorcontrib>Wang, Yungui</creatorcontrib><creatorcontrib>Xu, Huan</creatorcontrib><creatorcontrib>Tong, Hongyan</creatorcontrib><creatorcontrib>Zhu, Hong‐Hu</creatorcontrib><creatorcontrib>Jin, Jie</creatorcontrib><title>Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><subject>acute myeloid leukaemia</subject><subject>Acute myeloid leukemia</subject><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Bridged Bicyclo Compounds, Heterocyclic - therapeutic use</subject><subject>Chemotherapy</subject><subject>Cytarabine</subject><subject>Cytarabine - therapeutic use</subject><subject>Daunorubicin</subject><subject>Daunorubicin - therapeutic use</subject><subject>DAV</subject><subject>efficacy</subject><subject>Hematology</subject><subject>Humans</subject><subject>Leukemia, Myeloid, Acute - etiology</subject><subject>Remission Induction</subject><subject>Retrospective Studies</subject><subject>safety</subject><subject>venetoclax</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kbtuFDEUhkcIRJZAwQsgSzQgNIk9Vw8dREBAkWiAdnTGPsN68diDLwnTbUtHCY_FK-yT4GUDBRKWLDff_-kc_1l2n9ETls7psFmfMN7S7ka2YmVT5wWr2M1sRSltc0YrfpTd8X5DKStpzW5nR2XDmzLxq-znBzQYrNDwhcw6erLbfi92269P0q132x9kslKNCiVRJqDx6hKJWONkwxodzAu5UmFNJERjXRyUUIaAkUQsARwMymDKkVEFglqi0wuZISg0wR-C0QSHEJJeIjH20hIQMSCZFtRWSaIxfgKcFDwlQLwyHzXutt8E7mPEYXDWzyjCfiowoBev_N3s1gja473r9zh7__LFu7Pz_OLtq9dnzy5yUXLe5QBFJTo5NFUpOkE51II21SjGUQwDrziXKGn602qkLSAvRF20tKg6KWtZFNiVx9mjg3d29nNEH_pJeYFag0EbfV-0vKy6tijbhD78B93Y6NK8ieJJ2pYtaxL1-ECJtJV3OPazUxO4pWe03_fcp5773z0n9sG1MQ4Tyr_kn2ITcHoArpTG5f-m_vmb84PyF_97u8Y</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Wang, Huafeng</creator><creator>Yao, Yiyi</creator><creator>Mao, Liping</creator><creator>Lou, Yinjun</creator><creator>Ren, Yanling</creator><creator>Ye, Xingnong</creator><creator>Yang, Min</creator><creator>Ma, Liya</creator><creator>Zhang, Yi</creator><creator>Zhou, Yile</creator><creator>Wu, Jiaying</creator><creator>Huang, Xin</creator><creator>Wang, Yungui</creator><creator>Xu, Huan</creator><creator>Tong, Hongyan</creator><creator>Zhu, Hong‐Hu</creator><creator>Jin, Jie</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3625-2288</orcidid><orcidid>https://orcid.org/0000-0003-2343-0436</orcidid><orcidid>https://orcid.org/0000-0001-8428-1791</orcidid><orcidid>https://orcid.org/0000-0002-8360-6395</orcidid><orcidid>https://orcid.org/0000-0002-4420-0480</orcidid><orcidid>https://orcid.org/0000-0002-8166-9915</orcidid></search><sort><creationdate>202305</creationdate><title>Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis</title><author>Wang, Huafeng ; Yao, Yiyi ; Mao, Liping ; Lou, Yinjun ; Ren, Yanling ; Ye, Xingnong ; Yang, Min ; Ma, Liya ; Zhang, Yi ; Zhou, Yile ; Wu, Jiaying ; Huang, Xin ; Wang, Yungui ; Xu, Huan ; Tong, Hongyan ; Zhu, Hong‐Hu ; Jin, Jie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3889-aa24c9db643c9c08a5c064fcffcbb8488ded08704f07ae82c5270249dd5d22e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>acute myeloid leukaemia</topic><topic>Acute myeloid leukemia</topic><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Bridged Bicyclo Compounds, Heterocyclic - therapeutic use</topic><topic>Chemotherapy</topic><topic>Cytarabine</topic><topic>Cytarabine - therapeutic use</topic><topic>Daunorubicin</topic><topic>Daunorubicin - therapeutic use</topic><topic>DAV</topic><topic>efficacy</topic><topic>Hematology</topic><topic>Humans</topic><topic>Leukemia, Myeloid, Acute - etiology</topic><topic>Remission Induction</topic><topic>Retrospective Studies</topic><topic>safety</topic><topic>venetoclax</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Huafeng</creatorcontrib><creatorcontrib>Yao, Yiyi</creatorcontrib><creatorcontrib>Mao, Liping</creatorcontrib><creatorcontrib>Lou, Yinjun</creatorcontrib><creatorcontrib>Ren, Yanling</creatorcontrib><creatorcontrib>Ye, Xingnong</creatorcontrib><creatorcontrib>Yang, Min</creatorcontrib><creatorcontrib>Ma, Liya</creatorcontrib><creatorcontrib>Zhang, Yi</creatorcontrib><creatorcontrib>Zhou, Yile</creatorcontrib><creatorcontrib>Wu, Jiaying</creatorcontrib><creatorcontrib>Huang, Xin</creatorcontrib><creatorcontrib>Wang, Yungui</creatorcontrib><creatorcontrib>Xu, Huan</creatorcontrib><creatorcontrib>Tong, Hongyan</creatorcontrib><creatorcontrib>Zhu, Hong‐Hu</creatorcontrib><creatorcontrib>Jin, Jie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Huafeng</au><au>Yao, Yiyi</au><au>Mao, Liping</au><au>Lou, Yinjun</au><au>Ren, Yanling</au><au>Ye, Xingnong</au><au>Yang, Min</au><au>Ma, Liya</au><au>Zhang, Yi</au><au>Zhou, Yile</au><au>Wu, Jiaying</au><au>Huang, Xin</au><au>Wang, Yungui</au><au>Xu, Huan</au><au>Tong, Hongyan</au><au>Zhu, Hong‐Hu</au><au>Jin, Jie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2023-05</date><risdate>2023</risdate><volume>201</volume><issue>3</issue><spage>568</spage><epage>572</epage><pages>568-572</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>36863709</pmid><doi>10.1111/bjh.18709</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-3625-2288</orcidid><orcidid>https://orcid.org/0000-0003-2343-0436</orcidid><orcidid>https://orcid.org/0000-0001-8428-1791</orcidid><orcidid>https://orcid.org/0000-0002-8360-6395</orcidid><orcidid>https://orcid.org/0000-0002-4420-0480</orcidid><orcidid>https://orcid.org/0000-0002-8166-9915</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1048 |
| ispartof | British journal of haematology, 2023-05, Vol.201 (3), p.568-572 |
| issn | 0007-1048 1365-2141 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2783497237 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Free Content |
| subjects | acute myeloid leukaemia Acute myeloid leukemia Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bridged Bicyclo Compounds, Heterocyclic - therapeutic use Chemotherapy Cytarabine Cytarabine - therapeutic use Daunorubicin Daunorubicin - therapeutic use DAV efficacy Hematology Humans Leukemia, Myeloid, Acute - etiology Remission Induction Retrospective Studies safety venetoclax |
| title | Venetoclax plus ‘2 + 5’ modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single‐centre retrospective analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T14%3A53%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Venetoclax%20plus%20%E2%80%982%E2%80%89+%E2%80%895%E2%80%99%20modified%20intensive%20chemotherapy%20with%20daunorubicin%20and%20cytarabine%20in%20fit%20elderly%20patients%20with%20untreated%20de%20novo%20acute%20myeloid%20leukaemia:%20a%20single%E2%80%90centre%20retrospective%20analysis&rft.jtitle=British%20journal%20of%20haematology&rft.au=Wang,%20Huafeng&rft.date=2023-05&rft.volume=201&rft.issue=3&rft.spage=568&rft.epage=572&rft.pages=568-572&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.18709&rft_dat=%3Cproquest_cross%3E2783497237%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2802473716&rft_id=info:pmid/36863709&rfr_iscdi=true |